Skip to main content
Clinical Trials/NCT01944267
NCT01944267CompletedNot Applicable

Apically Positioned Flap, Free Gingival Graft and Apically Positioned Flap With Collagen Matrix Around Dental Implants

Tufts University2 sites in 1 country30 target enrollmentStarted: October 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
2
Primary Endpoint
Pain and discomfort survey

Study Overview

Brief Summary

This research study is looking at three different procedures for improving the oral mucosa (membrane) around dental implants. The three procedures will be the standard procedure, the standard procedure with the use of tissue harvested from the mouth and the standard procedure with the use of Mucograft membrane product. An advantage claimed by the Mucograft manufacturer is increased patient comfort due to lack of tissue harvesting from the mouth. Pain and discomfort levels will be evaluated for each of the procedures. Gain in oral mucosa and the visual will also be evaluated.

Detailed Description

Experimental Design

The study design for this research project will be a single centered, prospective randomized controlled trial. Subjects will be Tufts University School of Dental Medicine Department of Periodontology patients.

Sample Size and Statistical Analysis

There will be up to 22 subjects in each group, with a total of up to 66 subjects in the study. Up to 80 subjects will be enrolled in order to have 66 subjects completed the study. The calculation is based on 2 point difference in VAS pain and discomfort survey to have 80% power, while setting α=0.025 to adjust for the two primary outcomes (pain and discomfort) which gives 19 per each group. However, considering a 15% drop out rate, up to 22 subjects for each group will be recruited.

Data collected for analysis will be 10 point VAS from subjects' survey forms for the primary outcome. And 10 point VAS from esthetic evaluation, gain of keratinized mucosa measured by periodontal probe in millimeters with stent will be data for secondary outcome.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patient scheduled for 2nd stage implant surgery at the periodontology clinic of TUSDM.
  • Inadequate keratinized tissue (0.1mm- <2mm of buccal keratinized mucosa prior to the time of 2nd stage surgery) at the implant site. [4]
  • Adequate depth of buccal vestibule (>7 mm from the crest of ridge, measured at the center of surgical area) to accommodate gain of keratinized mucosa width.

Exclusion Criteria

  • Lack of keratinized mucosa on the area of implant.
  • Autoimmune conditions which may interfere with soft tissue healing in oral cavity, e.g., pemphigus vulgaris, phemphigoid
  • Infectious disease (self-reported - HIV, tuberculosis or hepatitis)
  • Pregnant patients, as part of TUSDM standard of care not to treat for non-emergency surgical procedures
  • Uncontrolled diabetes, defined as HbA1c >=7, values measured within six months
  • Previous gingival grafting procedure on the area.
  • Smoking (>3 cigarettes per day)
  • Subjects with known hypersensitivity to study materials or objection to use of porcine material (religious or cultural reasons)
  • Known allergy to codeine

Outcomes

Primary Outcomes

Pain and discomfort survey

Time Frame: 10 to 14 days follow up

A survey using VAS scale will be performed from the subjects at 10-14 days follow up visit.

Secondary Outcomes

  • Evaluation of full mouth gingival condition (periodontal parameters)(At 3-month and 6-month follow up appointments.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials